Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

67ed62.pY84jWnl8wLSO5pKCI_QY1K6QYzNZBNuvIpiknM1zb8.1OJBtBqTvHejT9AZbMbkBWvzMe2lFngaic9XpyUYic7cxUzcGo_DYIVu0w~283989c213596656472ef9a92fd162a7
08-28 Citigroup gives auto shares' rebound another boost DP
08-03 Forvia: Solid H1 beat despite China underperformance; FY26 guidance confirmed, deleveraging on track Alphavalue
08-03 Bargain buying in Forvia, Oddo BHF stays neutral Zonebourse
07-08 Forvia holds up thanks to Citi upgrade Zonebourse
07-01 Deutsche Bank Cuts Its Target on Forvia Zonebourse
06-26 Forvia keeps sliding despite Jefferies' positive view Zonebourse
04-30 Forvia: EPS cut (2025: from € -0.46 to -7.78, 2026: from € 1.22 to 0.88) Alphavalue
04-28 Jefferies applauds divestment of Forvia's Interiors business Zonebourse
04-08 Berenberg Updates Forvia Model After Q1 Pre-close Call; Price Target Cut on Sector De-rating MT
04-07 Forvia in the red as Berenberg forecasts 24% revenue drop for Q1 Zonebourse
03-11 Forvia slips despite support from Citigroup Zonebourse
03-04 Forvia: Resilient FY25 in a Tough Environment; Ambitious 2028 Targets Unveiled at CMD Alphavalue
02-26 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
01-20 Forvia lifts EPS after Q4 pre-close Alphavalue
11-25 Forvia revises EPS outlook after non-cash charge Alphavalue
25-10-21 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
25-10-21 Forvia: UBS still neutral after quarterly results Zonebourse
25-10-20 Forvia: Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
25-09-12 The stock market regains its cloak of invincibility Zonebourse
25-08-07 Forvia: Opinion change, from Sell to Reduce Alphavalue
25-07-30 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
25-07-29 Forvia: Deutsche Bank downgrades stock Zonebourse
25-07-29 Forvia: Solid H1 results ahead of expectations, FY25 guidance confirmed Alphavalue
25-07-29 Forvia: Oddo BHF raises target price Zonebourse
25-07-24 Forvia: NAV cut by -14.8% Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+48.3%
+69.5%
+48.7%
+12.41%
+66.59%
+33.18%
+4.82%
+1.89%
+9.79%
Average +32.80%
Weighted average by Cap. +37.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.590EUR
Average target price
14.43EUR
Spread / Average Target
+50.49%
High Price Target
39.00EUR
Spread / Highest target
+306.67%
Low Price Target
10.00EUR
Spread / Lowest Target
+4.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!